Patent · US Active

Heteroaryl butanoic acid derivatives

US12378206B2 · kind B2 · utility

0Cited by

5References

1Claims

0Family size

Assignee

Novartis AG · CH

Inventors

Birgit Bollbuck · Munich, DE
Christian Markert · Herbrechtingen, DE
Wolfgang Miltz · Basel, CH
Till Roehn · Zürich, CH

Key dates

Filing date	Aug 17, 2022
Grant date	Aug 5, 2025
Priority date	—
Expiry date	Nov 14, 2043

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D417/12
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention describes novel heteroaryl butanoic acid derivatives that are good drug candidates especially with regard to leukotriene A4 hydrolase (LTA4H). The present invention also relates to pharmaceutical compositions comprising said novel heteroaryl butanoic acid derivatives, methods of using said compounds in the treatment of various diseases and disorders, and processes for preparing the said novel compounds.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.